Moloney Securities Asset Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,243 shares of the healthcare conglomerate’s stock after purchasing an additional 809 shares during the period. Moloney Securities Asset Management LLC’s holdings in UnitedHealth Group were worth $1,614,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Regal Wealth Group Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after acquiring an additional 4 shares in the last quarter. RB Capital Management LLC lifted its stake in UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the last quarter. Highland Private Wealth Management lifted its stake in UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares during the last quarter. Finally, RNC Capital Management LLC lifted its stake in UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) traded up $0.57 during midday trading on Friday, reaching $221.82. 5,901,705 shares of the company’s stock traded hands, compared to its average volume of 2,766,697. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $214,958.67, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a 52 week low of $156.09 and a 52 week high of $231.77.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $2.17 EPS. sell-side analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s payout ratio is 33.26%.

Several research firms recently commented on UNH. Wells Fargo & Company reissued an “outperform” rating and set a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. BMO Capital Markets began coverage on shares of UnitedHealth Group in a research note on Monday, October 16th. They set an “outperform” rating and a $250.00 target price for the company. Citigroup increased their target price on shares of UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, Jefferies Group reissued a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a research note on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $224.56.

In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now owns 36,989 shares in the company, valued at approximately $8,218,955.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold a total of 12,032 shares of company stock valued at $2,658,310 over the last ninety days. 0.89% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.watchlistnews.com/moloney-securities-asset-management-llc-grows-position-in-unitedhealth-group-incorporated-unh/1769861.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.